Form 4 Tracker
Avidity Biosciences, Inc.
RNAM

17 insider filings · Latest: Feb 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 21, 2026Jan 23 10:34 PMSteven George HughesChief Medical Officer
Sale
4,895$72.45$354.6K31,599(D)

View →

Jan 21, 2026Jan 23 10:34 PMSarah BoyceDirector, President and CEO
Sale
14,387$72.45$1.0M269,007(D)

View →

Jan 21, 2026Jan 23 10:33 PMMichael W. FlanaganChief Scientific Officer
Sale
6,534$72.45$473.4K85,093(D)

View →

Jan 21, 2026Jan 23 10:33 PMMichael F MacleanChief Financial Officer
Sale
4,542$72.45$329.1K59,290(D)

View →

Jan 21, 2026Jan 23 10:33 PMLEVIN ARTHUR ADirector
Sale
1,758$72.45$127.4K16,562(D)

View →

Jan 21, 2026Jan 23 10:33 PMTeresa MccarthyChief Human Resources Officer
Sale
2,929$72.45$212.2K113,938(D)

View →

Sep 11, 2025Sep 11 8:24 PMWILLIAM MICHAEL FLANAGAN
Proposed Sale
20,000$46.40$928.0K

View →

Sep 5, 2025Sep 5 8:25 PMSARAH BOYCE
Proposed Sale
50,000$48.47$2.4M

View →

Sep 5, 2025Sep 5 8:10 PMWILSON TROY EDWARD
Proposed Sale
95,052$50.00$4.8M

View →

Sep 3, 2025Sep 3 8:31 PMERIC MOSBROOKER
Proposed Sale
19,688$47.23$929.9K

View →

Aug 28, 2025Aug 28 8:21 PMSARAH BOYCE
Proposed Sale
25,000$47.82$1.2M

View →

Aug 15, 2025Aug 15 8:27 PMTERESA MCCARTHY
Proposed Sale
45,000$46.07$2.1M

View →

Aug 13, 2025Aug 13 8:31 PMSTEVEN GEORGE HUGHES
Proposed Sale
9,709$46.23$448.8K

View →

Aug 6, 2025Aug 6 8:23 PMERIC MOSBROOKER
Proposed Sale
130,807$38.26$5.0M

View →

Aug 6, 2025Aug 6 8:23 PMSTEVEN GEORGE HUGHES
Proposed Sale
81,434$38.26$3.1M

View →

Aug 6, 2025Aug 6 8:23 PMARTHUR LEVIN
Proposed Sale
107,500$38.26$4.1M

View →

Aug 6, 2025Aug 6 8:22 PMMICHAEL MACLEAN
Proposed Sale
30,914$38.26$1.2M

View →

Aug 6, 2025Aug 6 8:08 PMWILSON TROY EDWARD
Proposed Sale
95,054$45.00$4.3M

View →

Jun 17, 2025Jun 17 8:19 PMKATHLEEN GALLAGHER
Proposed Sale
911$29.80$27.1K

View →

Jun 11, 2025Jun 11 8:31 PMWILLIAM MICHAEL FLANAGAN
Proposed Sale
20,000$33.62$672.4K

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 27, 2026Feb 27 8:28 PMTeresa MccarthyChief Human Resources Officer
Disposition
518,500$31.420(D)

View →

Feb 27, 2026Feb 27 8:26 PMTamar ThompsonDirector
Disposition
67,523$39.960(D)

View →

Feb 27, 2026Feb 27 8:24 PMMichael F MacleanChief Financial Officer
Disposition
587,375$31.420(D)

View →

Feb 27, 2026Feb 27 8:22 PMSimona SkerjanecDirector
Disposition
52,342$33.620(D)

View →

Feb 27, 2026Feb 27 8:20 PMSteven George HughesChief Medical Officer
Disposition
315,133$31.420(D)

View →

Feb 27, 2026Feb 27 8:19 PMSarah BoyceDirector, President and CEO
Disposition
2,176,015$31.420(D)

View →

Feb 27, 2026Feb 27 8:17 PMJohn B MoriartyChief Legal Officer
Disposition
210,000$44.570(D)

View →

Feb 27, 2026Feb 27 8:16 PMMichael W. FlanaganChief Scientific Officer
Disposition
397,500$31.420(D)

View →

Feb 27, 2026Feb 27 8:15 PMTroy Edward WilsonDirector
Disposition
38,523$39.960(D)

View →

Feb 27, 2026Feb 27 8:13 PMKathleen P. GallagherChief Program Officer
Disposition
208,330$44.000(D)

View →

Feb 27, 2026Feb 27 8:11 PMNoreen HenigDirector
Disposition
103,380$39.960(D)

View →

Feb 27, 2026Feb 27 8:05 PMJean Jinsun KimDirector
Disposition
97,523$39.960(D)

View →

Feb 27, 2026Feb 27 7:56 PMLEVIN ARTHUR ADirector
Disposition
295,523$39.960(D)

View →

Feb 27, 2026Feb 27 7:51 PMEdward M. Kaye MDDirector
Disposition
103,380$39.960(D)

View →

Feb 27, 2026Feb 27 7:50 PMCarsten BoessDirector
Disposition
103,381$39.960(D)

View →

Feb 27, 2026Feb 27 7:47 PMEric MosbrookerChief Commercial Officer
Disposition
227,188$31.420(D)

View →

Feb 27, 2026Feb 27 7:47 PMCharles Calderaro IIIChief Technical Officer
Disposition
80,000$31.420(D)

View →